ASRS
PVLA

Arizona State Retirement System’s Palvella Therapeutics PVLA Stock Holding History

Arizona State Retirement System’s Portfolio PVLA Stock Details PVLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$423K Buy
2,765
+652
+31% +$79.1K ﹤0.01% 1613
2026
Q1 		$263K Buy
+2,113
New +$220K ﹤0.01% 1782

Other funds holding PVLA

SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
FCM
Frontier Capital Management Boston, Massachusetts $10.7B AUM 67.78% 1-Year Est. Return

Arizona State Retirement System's PVLA Position: Q2 2026 in Review

Arizona State Retirement System increased its Palvella Therapeutics (PVLA) stake by 31% in Q2 2026, buying an estimated $79.1K and bringing the position to 2,765 shares worth $423K. The position accounts for ﹤0.01% of the portfolio, ranked #1613.

Arizona State Retirement System first reported a position in PVLA in Q1 2026 and has held it in 2 quarters since. 197 funds tracked by Wall St. Rank hold PVLA as of Q2 2026.

  • Arizona State Retirement System held 2,765 shares of Palvella Therapeutics worth $423K as of Q2 2026.
  • Arizona State Retirement System bought 652 Palvella Therapeutics shares in Q2 2026, an estimated $79.1K.
  • Palvella Therapeutics made up ﹤0.01% of Arizona State Retirement System's portfolio in Q2 2026, its #1613 holding.
  • Arizona State Retirement System first reported a position in Palvella Therapeutics in Q1 2026 and has held it in 2 quarters since.
  • 197 funds tracked by Wall St. Rank held Palvella Therapeutics as of Q2 2026.

Based on Arizona State Retirement System's 13F filing for Q2 2026, filed 7 Aug 2026.